Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

MULTIPLE

Active
SPE2DP-26-T-4366Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract specifies the procurement of MULTIPLE ELECTROLYTES INJECTION, TYPE 1, USP, in 1000 mL plastic bags, containing 14 units per case, with a pharmaceutical pH of 7.4. The product is manufactured by BAXTER HEALTHCARE CORPORATION under part number 2B2544X and is regulated by the FDA. It must be stored at room temperature, 25°C (77°F), with avoidance of excessive heat, and kept tightly closed in a cool, well-ventilated environment. The item has a non-extendable shelf life of 18 months as governed by RS001 for TYPE I (CODE K) classification and must be marked in accordance with the latest Medical Marking Standard No. 1. Packaging must comply with MIL-STD-2073-1E and the DLA packaging requirements, with latex-free plastic containers. The NSN is 6505014625492, and the unit of issue is PG, with a single unit ordered. Delivery is required within 20 days FOB destination, with zero tolerance for quantity variance and inspection and acceptance occurring at the destination. The solicitation number is SPE2DP-26-T-4366, issued by the Department of Defense’s Medical Supply Chain PHARM FSA with performance at Fort Bragg, North Carolina. Technical and quality requirements referenced under R numbers are governed by the DLA Master List of Technical and Quality Requirements, with revision control tied to the solicitation issue date. The contracting official must submit an EBS referral for FDA-regulated product confirmation, including bidder and manufacturer details. The contract was posted July 29, 2026, with a response deadline of August 4, 2026, under NAICS code 325412 for pharmaceutical preparation manufacturing.

General Info

Procure 1000 mL electrolyte injections, 18-month shelf life, FDA-regulated, FOB destination, 20-day delivery, NSN 6505014625492.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

5234 EAGLE TALON DR BLDG X3063, FORT BRAGG, NC, 28310, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts

Full Description

Show more
MULTIPLE
MULTIPLE ELECTROLYTES INJECTION, TYPE 1, USP. PH 7.4, 1000 ML, 14'S. U/I
"PG" (14'S). CASE DIMENSIONS 16"LG X 10"W X 10"H BAG, PLASTIC LATEX
FREE.KEEP CONTAINERS TIGHTLY CLOSED IN A COOL, WELL-VENTILATED PLACE.
STORE AT ROOM TEMPERATURE 25 °C (77 °F). AVOID EXCESSIVE HEAT.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS013: Shelf-life requirement RS001 for a TYPE I (CODE K) item with a shelf life of 18 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
BAXTER HEALTHCARE CORP IV 04687 P/N 2B2544X BAXTER HEALTHCARE CORPORATION 1G026 P/N 2B2544X
IAW REFERENCE REVISION NR DTD PART PIECE NUMBER:
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017656200 0001 PG 1.000
SPE2DP-26-T-4366
SECTION B
PR: 7017656200 PRLI: 0001 CONT’D
NSN/MATERIAL:6505014625492
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-462-5492 Quantity: 1 PG Purchase Request: 7017656200QTY: 1 Delivery: 20 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
ZINC OXIDE OINTMENT
Solicitation # SPE2DP-26-T-4364
The contract specifies the procurement of Zinc Oxide Ointment USP, a topical skin protectant containing 20% zinc oxide, supplied in collapsible tubes of 28.35 grams per unit, designated as a tube (TU). The product must be stored at controlled room temperature not exceeding 30°C (86°F) and has a non-extendable shelf life of 36 months as a Type I (Code Q) item. Packaging and labeling must strictly comply with MIL-STD-129 and the latest Medical Marking Standard No. 1, with all packaging requirements governed by the DLA Master List of Technical and Quality Requirements, which override ASTM D3951. The item is regulated by the FDA, requiring buyer referral for confirmation, and must be shipped via traceable means, excluding parcel post. All shipments are FOB destination with no quantity variance allowed, and inspection and acceptance occur at the delivery point. The item is identified by NSN 6505001501990 and manufacturer part number NDC67777-0223-11 from Dynarex Corp. Deliveries are split across six CLINs totaling 30 tubes, with delivery dates ranging from July 15 to July 30, 2026, directed to various military and government installations across the United States. Each delivery location has specific freight and marking instructions, including traceable carrier details and contract identifiers, and all must adhere to DLA packaging and palletization standards under RP001. The contract number is SPE2DP-26-T-4364 and the unit price is $3.00 per tube for all line items.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 17 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
BENZONATATE CAPSULES
Solicitation # SPE2DP-26-T-4357
BENZONATATE CAPSULES, USP, 100 MG, are supplied in bottles of 100 capsules each, with the active ingredient being 100 milligrams of benzonatate per capsule. The product must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F) and protected from light, moisture, and humidity. This item falls under a Type I (Code Q) shelf-life classification with a non-extendable shelf life of 36 months and must be marked in accordance with the latest edition of Medical Marking Standard No. 1. It is regulated by the FDA, and buyers are required to submit a referral via EBS to the product specialist, including bidder and manufacturer details such as names, part numbers, and NDC codes. The item is subject to DLA packaging requirements and technical quality standards referenced in the DLA Master List of Technical and Quality Requirements. The contract specifies delivery of four bottles under purchase request 7017663196, with delivery due within 20 days FOB destination, no variance allowed in quantity, and inspection and acceptance occurring at the destination. The NSN is 6505-00-660-1798, and the solicitation number is SPE2DP-26-T-4357, issued by the Department of Defense’s Medical Supply Chain PHARM FSA, with a response deadline of August 4, 2026. Primary point of contact is Imerah Burnett, and packaging must comply with MIL-STD-2073-1E.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 17 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
TRICHLOROACETIC ACID
Solicitation # SPE2DP-26-T-4354
The contract specifies the procurement of Trichloroacetic Acid, ACS grade, 80% concentration, in 15 mL units, identified by NSN 6505-01-363-7674 and part number 749887 from AmerisourceBergen Drug Corp. The item is classified as a TYPE I (CODE M) with a non-extendable shelf life of 24 months and must be packaged and marked in full compliance with Medical Marking Standard No. 1, superseding MIL-STD-129. Packaging must meet commercial standards with sealed unit containers and shipping containers capable of preventing damage during transit, ensuring safe delivery by common carrier at the lowest cost to the designated destination in APO, 09094-3219. The item is regulated by the FDA, requiring referral through EBS for confirmation, and delivery must occur within 20 days FOB destination with zero quantity variance allowed. Inspection and acceptance occur at the delivery point. Suppliers must provide Safety Data Sheets (SDS) and labels compliant with OSHA’s revised Hazard Communication Standard (29 C.F.R. 1910.1200), effective June 1, 2015, and must train employees on these requirements. All documentation must align with DLA’s Master List of Technical and Quality Requirements, and the unit of issue is BT, equivalent to 15 mL. The contract is issued under SPE2DP-26-T-4354, with a response deadline of August 4, 2026, and is governed by federal procurement regulations including DLA packaging and hazardous material handling standards.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 17 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
DIBUCAINE OINTMENT
Solicitation # SPE2DP-26-T-4358
Dibucaine Ointment USP is a topical pharmaceutical product containing one percent dibucaine as the active ingredient, specifically formulated for rectal administration and external use only. It is supplied in a collapsible tube and a rectal applicator, with each unit of issue being a single package containing one ounce or 28 grams of the ointment. Storage requirements mandate a temperature range of 15 to 30 degrees Celsius (59 to 86 degrees Fahrenheit). The product is regulated by the FDA and must be marked in accordance with the latest edition of Medical Marking Standard No. 1, with a non-extendable shelf life of 36 months as a Type I (Code Q) item. Packaging must comply with MIL-STD-2073-1E, and government identification must be removed from any non-accepted supplies. The contract specifies a procurement quantity of two packages, to be delivered FOB destination within 20 days, with zero variance allowed in quantity. The item is identified by NSN 6505002999535 and NDC 00536-1211-95, supplied by The Harvard Drug Group, L.L.C. The solicitation number is SPE2DP-26-T-4358, with a response deadline of August 4, 2026, and the place of performance is Nellis AFB, NV. The contract includes adherence to DLA’s Master List of Technical and Quality Requirements, and buyers must submit referrals in EBS to confirm product compliance prior to award.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 17 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
ALBUTEROL SULFATE INHA
Solicitation # SPE2DP-26-T-4353
Albuterol Sulfate Inhalation Aerosol with HFA is a prescription-only medication for oral inhalation, delivering 108 micrograms of albuterol sulfate per actuation, equivalent to 90 micrograms of albuterol base, supplied in an 8.5-gram canister containing 200 metered doses. The product must be stored at room temperature between 59°F and 77°F (15°C and 25°C), protected from extreme heat or cold, with specific warnings against puncturing, exposing to temperatures above 120°F, or spraying into the eyes. It has a non-extendable shelf life of 24 months and is classified as a TYPE I (CODE M) item under the Federal supply system. Labeling must include the National Stock Number, manufacturer date, expiration or retest date, contract number, and lot number, in compliance with the Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must meet commercial standards, with each unit sealed in a protective container and shipped in suitable exterior packaging to ensure safe delivery via common carrier. The product is regulated by the FDA and subject to Hazard Communication Standard requirements, mandating submission of Safety Data Sheets and compliant HCS labels aligned with 29 C.F.R. 1910.1200 prior to award, along with employee training on updated chemical labeling protocols. The contract specifies delivery of three units FOB destination within 20 days, with no variance allowed in quantity, and inspection and acceptance occurring at the delivery point. The NSN is 6505-01-543-6562, and the solicitation details identify Teva Pharmaceuticals USA, Inc. and Perrigo Direct Inc. as potential suppliers under procurement number SPE2DP-26-T-4353.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 17 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
VECURONIUM BROMIDE FOR
Solicitation # SPE2DP-26-T-4359
Vecuronium Bromide for Injection is a freeze-dried powder containing 10 mg of the active ingredient, supplied in packages of ten vials each, with a total shelf life of 24 months. At the time of receipt by the first government activity, the product must have a minimum of 21 months of remaining shelf life. The powder must be stored at controlled room temperature between 20 to 25°C (68 to 77°F) and protected from light, with containers retained in their outer cartons until use. Packaging and labeling must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and all units must be sealed and packaged in commercial shipping containers that ensure safe delivery via common carrier at the lowest rate. The product is not considered hazardous under FED-STD-313 and must be packaged in accordance with ASTM D3951, though DLA’s Master List of Technical and Quality Requirements takes precedence. Shipments must be sent by traceable means only; parcel post is prohibited. Deliveries are FOB destination with zero variance allowed, and inspection and acceptance occur upon arrival. The supplier is Hikma Pharmaceuticals USA Inc., with NDC 00143-9234-10, and the contract requires multiple deliveries across different locations and dates in July 2026, totaling eight line items for one or three packages per delivery. All packaging, palletization, and labeling must adhere to DLA Packaging Requirements for Procurement and specific storage and handling instructions.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 17 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
PETROLATUM, WHITE
Solicitation # SPE2DP-26-T-4355
The contract specifies the procurement of 8 units (TU) of white petrolatum, USP, with each TU equaling 28 milligrams, for a total quantity of 224 milligrams. The material must comply with stringent packaging and marking requirements per the Medical Marking Standard No. 1, replacing all references to MIL-STD-129, and must be packaged in sealed commercial unit containers that protect against damage, with exterior shipping containers ensuring safe, cost-effective delivery to the destination. The item is classified as a TYPE I (CODE Q) with a non-extendable shelf life of 36 months and must be shipped by the fastest traceable means, excluding parcel post. Delivery is required within five days of award under FOB destination terms with zero quantity variance permitted and acceptance occurring at the delivery point. The product must be commercially packaged per ASTM D3951 unless deemed hazardous under FED-STD-313, in which case TQ requirement IP025 applies; however, all DLA Master List of Technical and Quality Requirements override any conflicting standards. Packaging and labeling must reflect the specified unit of issue and quantity per unit pack, and palletization must adhere to DLA packaging guidelines. The delivery address is for the 0182 IN BN 01 HHC INFANTRY BN in Melrose, MA, with the required delivery date set for July 30, 2026, and the contract reference number is SPE2DP-26-T-4355.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 17 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
TYPHOID VI POLYSACCHAR
Solicitation # SPE2DP-26-T-4363
The contract specifies the procurement of Typhoid Vi Polysaccharide Vaccine, a modified acellular vaccine supplied in 10 mL vials, with a total quantity of 10 vials, each containing 20 doses. The vaccine must adhere to the Medical Procurement Item Description (MPID) No. 3 dated 20 March 2006, with modifications including the substitution of “vial” for “box” in packaging references. The product must have a minimum shelf life of 18 months, with at least 15 months remaining at the time of delivery to the first government activity, and this shelf-life requirement is non-extendable. The vaccine requires constant refrigeration between 2 and 8 degrees Celsius (36 to 46 degrees Fahrenheit) throughout transport and storage, and all packaging, labeling, and marking must comply with the latest edition of the Medical Marking Standard No. 1 and MIL-STD-129. Commercial packaging must conform to ASTM D3951 unless overridden by DLA’s Master List of Technical and Quality Requirements, which take precedence. The product is to be delivered FOB destination within five days of the contract award, with no variance allowed in quantity. Delivery is directed to USS RALPH JOHNSON DDG 114 at FPO AP 96691-3300, with transportation governed by DLAD procedure notes C19 and C20. The contract is tied to NSN 6505-01-385-6328 and solicitation SPE2DP-26-T-4363, with an original required delivery date of 31 July 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 17 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
SUMATRIPTAN SUCCINA
Solicitation # SPE2DP-26-T-4365
Sumatriptan succinate tablets, 25 mg film-coated, are provided in bottles of nine tablets for the acute treatment of migraine with or without aura in adults and must be stored at controlled room temperature between 20 to 25 °C (68 to 77 °F) with protection from light. The contract specifies adherence to strict packaging and marking standards including MIL-STD-2073-1E and MIL-STD-129, with palletization following DLA packaging requirements and shelf life constrained to 24 months under Type I (Code M) non-extendable limits. Deliveries are scheduled for multiple military installations across Fort Bliss, Fort Hood, and Fort Bragg with firm delivery windows of 20 days and no variance allowed in quantity. Each shipment must be transported via traceable means excluding parcel post, with inspection and acceptance occurring at the destination. The contract includes multiple line items under solicitation SPE2DP-26-T-4365, totaling 54 units (nine-tablet bottles), with delivery dates ranging from April to July 2026, and all items carry the same NSN 6505017246289. The supplier must comply with technical and quality requirements referenced from the DLA Master List, and all labeling and documentation must conform to the Medical Marking Standard No. 1 and government-specific identifiers. Contract performance is tracked through detailed logistics codes, tracking numbers, and government-specific identifiers for procurement, distribution, and accountability.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 17 hours ago

DEADLINE

in 5 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 424210
New
DIBBS
BENZOIN TINCTURE, COMPO
Solicitation # SPE2DP-26-T-4356
Benzoin Tincture, Compound, USP is an over-the-counter topical product intended for external use only, containing 1000 mg of Benzoin Resin per milliliter as the active ingredient and 77 percent alcohol as an inactive ingredient. It is supplied in 16-ounce bottles, equivalent to one pint or 473 milliliters, and is classified as a flammable substance requiring storage between 20°C and 25°C in accordance with USP controlled room temperature standards. The item has a non-extendable shelf life of 36 months, and any delivery to the first government activity must ensure a minimum of 31 months of remaining shelf life at the time of receipt. This product is regulated by the FDA and is subject to hazardous materials requirements, including the mandatory inclusion of a current Material Safety Data Sheet (MSDS) with every shipment and electronic submission to DLA.MSDS@DLA.MIL using the required cover sheet P-75. Packaging must comply with 49 CFR and ICAO regulations for hazardous materials, and all items must be marked in accordance with Medical Marking Standard No. 1, superseding MIL-STD-129. The item is covered under Defense Information potentially applicable provisions and incorporates technical and quality requirements from the DLA Master List. It is identified by NSN 6505-01-654-9628 under solicitation SPE2DP-26-T-4356, with a 20-day delivery deadline and procurement through the Department of Defense’s Medical Supply Chain.
Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

about 17 hours ago

DEADLINE

in 5 days
View Details
New
DIBBS
APPLICATOR, SILVER NITR
Solicitation # SPE2DP-26-Q-0124
The contract calls for the procurement of silver nitrate applicators, each consisting of a 75% silver nitrate and 25% potassium nitrate mixture fused to a 6-inch (1.524 cm) tip, packaged in containers of 100 units, for topical medical use only and regulated by the FDA. All units must be stored in sealed packages at room temperature in a dark, dry location away from oxidizable materials, and the item carries a non-extendable 24-month shelf life as a TYPE I (CODE M) item under DLA’s requirements. The product is identified by NSN 6505-00-299-9672 and is subject to hazardous materials handling protocols, requiring a current Material Safety Data Sheet (MSDS) to accompany each shipment and be submitted electronically to DLA.MSDS@DLA.MIL. Packaging and labeling must strictly comply with MIL-STD-2073-1E and Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical acquisitions, ensuring proper barcoding and inspection readiness. Delivery is to occur within 15 days of an As Directed Order to multiple DoD medical facilities, with FOB destination terms placing responsibility for transportation and risk on the contractor. The contract is firm fixed price, requires electronic invoicing through Wide Area WorkFlow, and mandates adherence to comprehensive cybersecurity, supply chain security, and government information safeguarding protocols including DFARS 252.204-7012 and 252.204-7018. Ocean transportation must use U.S.-flag vessels unless a waiver is secured with 45-day notice and supporting documentation, and contractors must ensure all subcontractors comply with applicable regulations. The solicitation, open for response through August 3, 2026, is issued by the Department of Defense's Medical Supply Chain Pharm FSA through DLA Troop Support, with procurement activities managed under specific FAR and DFARS clauses covering subcontracting, equal opportunity, payment integrity, and prohibitions on foreign-sourced telecommunications and covered applications.

POSTED

about 17 hours ago

DEADLINE

in 4 days
View Details